Other studied have noted minor differences between the sexes in analgesic responses to systemically administered drugs, with most work being performed with opioids. We note in preliminary experiments a 2- fold increase in potency of intrathecal neostigmine in women volunteers and patients compared to men. Frequency and intensity of side effects are not different between men and women. Positron emission tomography (PET) studies in rhesus monkeys support an estrogen-dependent increase in spinal cholinergic activity in females, and studies in rats demonstrated a 5 to 10-fold increase in antinociceptive potency of intrathecal neostigmine in females. This sex difference in analgesic potency applies equally to acute nociceptive responses as well as subacute and chronic models of hyperalgesia and allodynia. We propose a 5 year series of in vitro and in vivo studies in rats and humans to establish the magnitude and pharmacology of this increased sensitivity to cholinoceptive agents in females and to examine pharmacologic and neurobiologic mechanisms responsible for this increased sensitivity. Specifically, we will test whether this sex difference reflects altered neurotransmitter release, postsynaptic receptor expression, second messenger generation and neuroplasticity, or neurotransmitter interactions. We will perform in vivo spinal cord cholinergic imaging in humans with PET under Project V. Sex differences and hormonal dependent responses will be examined and mechanisms explored. Since intrathecally administered neostigmine has already demonstrated efficacy in clinical trials, and since nicotinic receptor subtype selective agents and novel cholinesterase inhibitors for systemic administration are under active clinical development for other indications, these studies will be instrumental to the understanding and development of systemic and intrathecal therapy for acute and chronic pain in women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS041386-01A1
Application #
6575401
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2002-02-15
Project End
2007-01-31
Budget Start
Budget End
2003-01-31
Support Year
1
Fiscal Year
2002
Total Cost
$206,161
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Rauck, Richard L; North, James; Eisenach, James C (2015) Intrathecal clonidine and adenosine: effects on pain and sensory processing in patients with chronic regional pain syndrome. Pain 156:88-95
Peters, Christopher M; Hayashida, Ken-ichiro; Ewan, Eric E et al. (2010) Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat. Brain Res 1352:83-93
Hayashida, Ken-Ichiro; Clayton, Bridgette A; Johnson, James E et al. (2008) Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain 136:348-55
Yan, Tao; Liu, Baogang; Du, Dongping et al. (2007) Estrogen amplifies pain responses to uterine cervical distension in rats by altering transient receptor potential-1 function. Anesth Analg 104:1246-50, tables of contents
Clayton, Bridgette A; Hayashida, Ken-ichiro; Childers, Steven R et al. (2007) Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism. Anesthesiology 106:1019-25
Martin, Thomas J; Kim, Susy A; Buechler, Nancy L et al. (2007) Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 106:312-22
Hayashida, Ken-Ichiro; DeGoes, Sophia; Curry, Regina et al. (2007) Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106:557-62
Romero-Sandoval, Alfonso; Bynum, Tanishua; Eisenach, James C (2007) Analgesia induced by perineural clonidine is enhanced in persistent neuritis. Neuroreport 18:67-71
Romero-Sandoval, Alfonso; Eisenach, James C (2007) Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 106:787-94
Romero-Sandoval, Alfonso; Eisenach, James C (2007) Clonidine reduces hypersensitivity and alters the balance of pro- and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis. Brain Behav Immun 21:569-80

Showing the most recent 10 out of 83 publications